Related Experiment Videos
Hyposplenism in systemic lupus erythematosus
The Journal of Rheumatology
|April 1, 1983
Summary
This study found that approximately 5% of patients with systemic lupus erythematosus (SLE) exhibit hyposplenism, a condition indicating reduced splenic function. This suggests a notable association between SLE and impaired spleen activity.
Area of Science:
- Immunology
- Rheumatology
- Hematology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex pathophysiology.
- Splenic function plays a crucial role in immune regulation and clearance of aged or damaged cells.
- Hyposplenism, characterized by reduced splenic function, has been anecdotally linked to various autoimmune conditions.
Purpose of the Study:
- To investigate the prevalence of hyposplenism in patients diagnosed with systemic lupus erythematosus (SLE).
- To assess the relationship between splenic function and SLE activity.
- To determine the incidence of hyposplenism in an SLE cohort.
Main Methods:
- Evaluated splenic function in 44 SLE patients using phase contrast microscopy to quantify vacuolated red blood cells (RBCs).
- Increased percentages of vacuolated RBCs were used as an indicator of hyposplenism.
- Follow-up assessments were conducted over 2 to 4 months for patients identified with hyposplenism.
Main Results:
- Two out of 44 SLE patients (4.6%) demonstrated significantly elevated percentages of vacuolated RBCs (8.4% and 30.6%), indicative of hyposplenism.
- These patients had inactive disease, were on low-dose corticosteroids, and showed persistent vacuolated RBCs upon re-evaluation.
- The overall estimated incidence of hyposplenism in this SLE cohort was approximately 5%.
Conclusions:
- The study confirms a significant association between systemic lupus erythematosus (SLE) and hyposplenism.
- Hyposplenism appears to be present in a small but notable percentage of SLE patients, irrespective of disease activity.
- These findings highlight the importance of considering splenic function in the management and understanding of SLE.